Cheryl Attard

401 total citations
10 papers, 317 citations indexed

About

Cheryl Attard is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Cheryl Attard has authored 10 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Cheryl Attard's work include Health Systems, Economic Evaluations, Quality of Life (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Electrolyte and hormonal disorders (2 papers). Cheryl Attard is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Electrolyte and hormonal disorders (2 papers). Cheryl Attard collaborates with scholars based in Canada, United States and United Kingdom. Cheryl Attard's co-authors include Margaret Hux, George W. Torrance, Michele Kohli, Gordana Atanackovic, Cathy J. Bradley, Suzanne Coleman, Michael Marentette, R. Gary Sibbald, John K. Marshall and James M. Pellissier and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Obstetrics and Gynecology and PharmacoEconomics.

In The Last Decade

Cheryl Attard

10 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheryl Attard Canada 8 165 75 53 44 42 10 317
Manami Inoue Japan 11 131 0.8× 23 0.3× 11 0.2× 16 0.4× 16 0.4× 17 378
G. Keith Chambers Canada 7 24 0.1× 104 1.4× 47 0.9× 20 0.5× 113 2.7× 11 455
Carlo Tringale United States 4 19 0.1× 185 2.5× 21 0.4× 16 0.4× 27 0.6× 5 498
J.‐C. Todd United Kingdom 5 151 0.9× 28 0.4× 57 1.1× 38 0.9× 39 0.9× 6 362
Elizabeth Brettell United Kingdom 11 31 0.2× 33 0.4× 17 0.3× 105 2.4× 91 2.2× 15 474
Devi Kundu United Kingdom 4 85 0.5× 23 0.3× 34 0.6× 19 0.4× 17 0.4× 5 330
Ilan I. Maizlin United States 11 25 0.2× 93 1.2× 36 0.7× 40 0.9× 23 0.5× 18 343
Jennifer Nicol Australia 11 55 0.3× 29 0.4× 77 1.5× 23 0.5× 15 0.4× 27 389
Aida Fallahzadeh Iran 10 34 0.2× 53 0.7× 10 0.2× 16 0.4× 31 0.7× 32 231
Houman Tahmasebi Canada 11 44 0.3× 34 0.5× 36 0.7× 14 0.3× 18 0.4× 16 276

Countries citing papers authored by Cheryl Attard

Since Specialization
Citations

This map shows the geographic impact of Cheryl Attard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Attard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Attard more than expected).

Fields of papers citing papers by Cheryl Attard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl Attard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Attard. The network helps show where Cheryl Attard may publish in the future.

Co-authorship network of co-authors of Cheryl Attard

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl Attard. A scholar is included among the top collaborators of Cheryl Attard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl Attard. Cheryl Attard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Patel, Leena, et al.. (2014). Real-world experience with FOLFIRINOX: a review of Canadian and international registries. 5 indexed citations
2.
Attard, Cheryl, et al.. (2012). Cost-effectiveness of FOLFIRINOX for first-line treatment of metastatic pancreatic cancer.. Journal of Clinical Oncology. 30(4_suppl). 199–199. 8 indexed citations
3.
Grima, Daniel, et al.. (2010). Modelled cost-effectiveness of high cut-off haemodialysis compared to standard haemodialysis in the management of myeloma kidney. Current Medical Research and Opinion. 27(2). 383–391. 10 indexed citations
4.
Grima, Daniel, Lawrence A. Leiter, Shaun G. Goodman, et al.. (2008). How many cardiovascular events can be prevented with optimal management of high-risk Canadians?. Canadian Journal of Cardiology. 24(5). 363–368. 6 indexed citations
5.
Churchill, David, David Macarios, Cheryl Attard, Joel Kallich, & Ron Goeree. (2007). Costs Associated with Erythropoiesis-Stimulating Agent Administration to Hemodialysis Patients. Nephron Clinical Practice. 106(4). c193–c198. 12 indexed citations
6.
Kohli, Michele, Cheryl Attard, Annette Lam, et al.. (2006). Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada. PharmacoEconomics. 24(8). 815–830. 18 indexed citations
7.
Sibbald, R. Gary, et al.. (2003). Cost-effectiveness of becaplermin for nonhealing neuropathic diabetic foot ulcers.. PubMed. 49(11). 76–84. 48 indexed citations
8.
Attard, Cheryl, Michele Kohli, Suzanne Coleman, et al.. (2002). The burden of illness of severe nausea and vomiting of pregnancy in the United States. American Journal of Obstetrics and Gynecology. 186(5). S220–S227. 151 indexed citations
9.
Marshall, John K., James M. Pellissier, Cheryl Attard, Sheldon X. Kong, & Michael Marentette. (2001). Incremental Cost-Effectiveness Analysis Comparing Rofecoxib with Nonselective NSAIDs in Osteoarthritis. PharmacoEconomics. 19(10). 1039–1049. 39 indexed citations
10.
Koren, Gideon, Laura A. Magee, Cheryl Attard, et al.. (2001). A novel method for the evaluation of the severity of nausea and vomiting of pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 94(1). 31–36. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manami Inoue Breakdown of academic impact, for papers by G. Keith Chambers Breakdown of academic impact, for papers by Carlo Tringale Breakdown of academic impact, for papers by J.‐C. Todd Breakdown of academic impact, for papers by Elizabeth Brettell Breakdown of academic impact, for papers by Devi Kundu Breakdown of academic impact, for papers by Ilan I. Maizlin Breakdown of academic impact, for papers by Jennifer Nicol Breakdown of academic impact, for papers by Aida Fallahzadeh Breakdown of academic impact, for papers by Houman Tahmasebi
Rankless by CCL
2026